Latest Insider Transactions at Ingevity Corp (NGVT)
This section provides a real-time view of insider transactions for Ingevity Corp (NGVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ingevity Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ingevity Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 05
2024
|
Ryan C. Fisher SVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
1,163
+9.48%
|
-
|
|
Jul 01
2024
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
191
-1.3%
|
$8,022
$42.18 P/Share
|
|
May 03
2024
|
Ryan C. Fisher SVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
756
-7.06%
|
$40,068
$53.56 P/Share
|
|
Apr 24
2024
|
Jean S Blackwell |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+38.65%
|
-
|
|
Apr 24
2024
|
Diane H. Gulyas |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+24.08%
|
-
|
|
Apr 24
2024
|
Luis M Fernandez Moreno |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+11.13%
|
-
|
|
Apr 24
2024
|
Frederick J Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+11.15%
|
-
|
|
Apr 24
2024
|
Bruce D. Hoechner |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+36.98%
|
-
|
|
Apr 24
2024
|
Karen G Narwold |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+17.79%
|
-
|
|
Apr 24
2024
|
Benjamin G. Wright |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+31.87%
|
-
|
|
Apr 24
2024
|
Daniel F Sansone |
BUY
Grant, award, or other acquisition
|
Direct |
2,800
+17.92%
|
-
|
|
Apr 19
2024
|
Mary Dean Hall EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,227
-3.26%
|
$97,988
$44.44 P/Share
|
|
Feb 28
2024
|
Steven Paul Hulme SVP and Pres, APT |
BUY
Grant, award, or other acquisition
|
Direct |
2,431
+26.25%
|
-
|
|
Feb 28
2024
|
Steven Paul Hulme SVP and Pres, APT |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-8.75%
|
$11,115
$45.27 P/Share
|
|
Feb 28
2024
|
Phillip John Platt CAO & VP, Bus Transform Lead |
BUY
Grant, award, or other acquisition
|
Direct |
3,591
+9.89%
|
-
|
|
Feb 28
2024
|
Phillip John Platt CAO & VP, Bus Transform Lead |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-1.29%
|
$15,255
$45.27 P/Share
|
|
Feb 28
2024
|
Christine Stunyo SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
351
-3.87%
|
$15,795
$45.27 P/Share
|
|
Feb 28
2024
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
BUY
Grant, award, or other acquisition
|
Direct |
9,201
+12.77%
|
-
|
|
Feb 28
2024
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
818
-1.69%
|
$36,810
$45.27 P/Share
|
|
Feb 28
2024
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
BUY
Grant, award, or other acquisition
|
Direct |
8,236
+22.7%
|
-
|
|
Feb 28
2024
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
533
-3.88%
|
$23,985
$45.27 P/Share
|
|
Feb 28
2024
|
Mary Dean Hall EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
12,710
+16.24%
|
-
|
|
Feb 28
2024
|
Mary Dean Hall EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
855
-1.92%
|
$38,475
$45.27 P/Share
|
|
Feb 28
2024
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,978
+17.68%
|
-
|
|
Feb 28
2024
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
627
-2.06%
|
$28,215
$45.27 P/Share
|
|
Feb 28
2024
|
John C. Fortson President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
50,451
+14.81%
|
-
|
|
Feb 28
2024
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,592
-2.19%
|
$206,640
$45.27 P/Share
|
|
Feb 26
2024
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
3,475
-6.29%
|
$166,800
$48.11 P/Share
|
|
Feb 26
2024
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
208
-1.34%
|
$9,984
$48.11 P/Share
|
|
Feb 26
2024
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,377
-1.28%
|
$66,096
$48.11 P/Share
|
|
Feb 26
2024
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
77
-1.09%
|
$3,696
$48.11 P/Share
|
|
Feb 26
2024
|
Phillip John Platt CAO & VP, Bus Transform Lead |
SELL
Payment of exercise price or tax liability
|
Direct |
81
-0.61%
|
$3,888
$48.11 P/Share
|
|
Feb 22
2024
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
SELL
Payment of exercise price or tax liability
|
Direct |
310
-4.2%
|
$14,570
$47.4 P/Share
|
|
Feb 22
2024
|
Richard Allen White Jr SVP and Pres, Perf Chemicals |
BUY
Grant, award, or other acquisition
|
Direct |
845
+10.28%
|
-
|
|
Feb 22
2024
|
Phillip John Platt CAO & VP, Bus Transform Lead |
SELL
Payment of exercise price or tax liability
|
Direct |
266
-1.97%
|
$12,502
$47.4 P/Share
|
|
Feb 22
2024
|
Phillip John Platt CAO & VP, Bus Transform Lead |
BUY
Grant, award, or other acquisition
|
Direct |
724
+5.08%
|
-
|
|
Feb 22
2024
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
857
-5.23%
|
$40,279
$47.4 P/Share
|
|
Feb 22
2024
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,662
+13.97%
|
-
|
|
Feb 22
2024
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-4.21%
|
$57,622
$47.4 P/Share
|
|
Feb 22
2024
|
Stuart Edward Woodcock Jr. EVP and Pres, Perf Materials |
BUY
Grant, award, or other acquisition
|
Direct |
2,563
+8.09%
|
-
|
|
Feb 22
2024
|
John C. Fortson President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,527
-4.9%
|
$259,769
$47.4 P/Share
|
|
Feb 22
2024
|
John C. Fortson President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,934
+9.58%
|
-
|
|
Feb 22
2024
|
Mary Dean Hall EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
587
-2.55%
|
$27,589
$47.4 P/Share
|
|
Feb 22
2024
|
Mary Dean Hall EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
1,558
+6.34%
|
-
|
|
Feb 01
2024
|
Stacy Cozad EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
887
-6.07%
|
$39,028
$44.33 P/Share
|
|
Sep 28
2023
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
467
+8.49%
|
$22,416
$48.18 P/Share
|
|
Jul 24
2023
|
Phillip John Platt CAO & VP, Bus Transform Lead |
BUY
Grant, award, or other acquisition
|
Direct |
7,263
+36.21%
|
-
|
|
Jul 03
2023
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
384
+7.76%
|
$22,272
$58.62 P/Share
|
|
Jun 27
2023
|
Christine Stunyo SVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-12.42%
|
$70,840
$55.52 P/Share
|
|
Apr 28
2023
|
William J Slocum Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,645
+28.23%
|
-
|